After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Solid Biosciences Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Solid Biosciences Inc is $370.42M. A total of 1.16 million shares were traded on the day, compared to an average of 2.39M shares.
In the most recent transaction, Kahn Clare bought 1,860 shares of SLDB for 5.34 per share on Mar 11 ’25. After the transaction, the Director now owns 2,960 company shares. In a previous transaction on Feb 19 ’25, Bain Capital Life Sciences Inv bought 1,000,000 shares at 4.03 per share. SLDB shares that 10% Owner owns now total 5,034,582.
Among the insiders who bought shares, PERCEPTIVE ADVISORS LLC acquired of 5,000,000 shares on Feb 19 ’25 at a per-share price of $4.03. This resulted in the Director holding 11,833,539 shares of SLDB after the transaction. In another insider transaction, Adage Capital Management, L.P. bought 252,545 shares at $7.56 per share on Feb 18 ’25. Company shares held by the 10% Owner now total 4,248,084.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SLDB has a high of $15.05 and a low of $2.88.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SLDB’s latest balance sheet shows that the firm has $207.78M in Cash & Short Term Investments as of fiscal 2021. There were $2.06M in debt and $23.60M in liabilities at the time. Its Book Value Per Share was $3.39, while its Total Shareholder’s Equity was $208.21M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLDB is Buy with a score of 5.00.
